MKI67 and neoplasm: Concomitant with the results obtained for in vivo tumor growth inhibition, we also observed decreased proliferation as documented by PCNA and Ki-67 immunostaining, and increased apoptosis as documented by decreased Survivin expression within tumor tissues.